(Q38156421)

29 August 2017

Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis (English)

1 reference

29 August 2017

cutaneous leishmaniasis

1 reference

Begoña Monge-Maillo

1

1 reference

PubMed ID

24170665

29 August 2017

Rogelio López-Vélez

series ordinal

2

1 reference

29 August 2017

1 November 2013

1 reference

29 August 2017

1 reference

29 August 2017

73

1 reference

29 August 2017

17

1 reference

29 August 2017

1889-1920

1 reference

https://scigraph.springernature.com/pub.10.1007/s40265-013-0132-1

29 August 2017

0 references

cites work

Treatment of New World cutaneous leishmaniasis with miltefosine

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Leishmaniasis worldwide and global estimates of its incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

The efficacy of thermotherapy to treat cutaneous leishmaniasis in Colombia: a comparative observational study in an operational setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Treatment of cutaneous leishmaniasis with nitric-oxide donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Adverse effects of intralesional Glucantime in the treatment of cutaneous leishmaniosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Challenges and new discoveries in the treatment of leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Cutaneous leishmaniasis in Afghani refugees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Cutaneous leishmaniasis in India. Clinical experience with itraconazole (R51 211 Janssen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

First case of typical Old World cutaneous leishmaniasis treated with miltefosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Cutaneous infection with Leishmania infantum in an infant treated successfully with miltefosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Miltefosine for new world cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Treatment of imported New World cutaneous leishmaniasis in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of azithromycin in the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

A new rural focus of cutaneous leishmaniasis caused by Leishmania tropica in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Studies on the leishmaniases in the Sudan. 2. Clinical and parasitological studies on cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Successful treatment of antimony-resistant cutaneous leishmaniasis with liposomal amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Cutaneous leishmaniasis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Itraconazole in the treatment of New World mucocutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Cutaneous leishmaniasis in the Metropolitan Region of Belo Horizonte: clinical, laboratorial, therapeutic and prognosis features (1989-1995)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Topical paromomycin with or without gentamicin for cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Diffuse cutaneous leishmaniasis with mucosal involvement in Colombia, caused by an enzymatic variant of Leishmania panamensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0132-1

Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam).

21 January 2018

1 reference

12 December 2020

Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial

1 reference

12 December 2020

Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major

1 reference

12 December 2020

Cutaneous leishmaniasis

1 reference

12 December 2020

Efficacy of intra-lesional glucantime in the treatment of zoonotic cutaneous leishmaniasis in basic health care conditions

1 reference

12 December 2020

Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.

1 reference

12 December 2020

Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia

1 reference

12 December 2020

Treatment of Bolivian mucosal leishmaniasis with miltefosine

1 reference

12 December 2020

Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia

1 reference

12 December 2020

Guide to development of practice guidelines

1 reference

12 December 2020

Diffuse cutaneous leishmaniasis in Mexico

1 reference

12 December 2020

Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis

1 reference

12 December 2020

Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species

1 reference

12 December 2020

Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis

1 reference

12 December 2020

Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala

1 reference

12 December 2020

A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment

1 reference

12 December 2020

A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis

1 reference

12 December 2020

[Comparative study of meglumine antimoniate, pentamidine isethionate and aminosidine sulfate in the treatment of primary skin lesions caused by Leishmania (Viannia) braziliensis]

1 reference

12 December 2020

Efficacy and Toxicity of Pentostam against Panamanian Mucosal Leishmaniasis

1 reference

12 December 2020

An Australian case of New World cutaneous leishmaniasis.

1 reference

12 December 2020

Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis

1 reference

12 December 2020

Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis

1 reference

12 December 2020

Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.

1 reference

12 December 2020

Allopurinol in the Treatment of American Cutaneous Leishmaniasis

1 reference

12 December 2020

Use of itraconazole in the treatment of mucocutaneous leishmaniasis: a pilot study

1 reference

12 December 2020

Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis

1 reference

12 December 2020

A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis

1 reference

12 December 2020

A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran

1 reference

12 December 2020

[Treatment of american cutaneous leishmaniasis, with lesions in the mucosa, using pentamidine isethionate]

1 reference

12 December 2020

Recommendations for Treating Leishmaniasis with Sodium Stibogluconate (Pentostam) and Review of Pertinent Clinical Studies

1 reference

12 December 2020

[Spontaneous course of lesions of Leishmania major cutaneous leishmaniasis in Tunisia]

1 reference

12 December 2020

Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.

1 reference

12 December 2020

[Treatment of mucosal leishmaniasis with aminosidine sulfate: results of two year follow-up]

1 reference

12 December 2020

Azithromycin in the treatment of mucosal leishmaniasis

1 reference

12 December 2020

Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala

1 reference

12 December 2020

A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran

1 reference

12 December 2020

Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine

1 reference

12 December 2020

Placebo Controlled Treatment of Ecuadorian Cutaneous Leishmaniasis

1 reference

12 December 2020

Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99

1 reference

12 December 2020

[Treatment of mucocutaneous leishmaniasis with pentamidine isothionate]

1 reference

12 December 2020

A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel

1 reference

12 December 2020

A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis

1 reference

12 December 2020

A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis

1 reference

12 December 2020

Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis

1 reference

12 December 2020

Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment

1 reference

12 December 2020

Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B

1 reference

12 December 2020

The clinical and immunological spectrum of American cutaneous leishmaniasis

1 reference

12 December 2020

Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis

1 reference

12 December 2020

Cryotherapy in acute cutaneous leishmaniasis

1 reference

12 December 2020

Liposomal amphotericin B treatment of cutaneous leishmaniasis contracted in Djibouti and resistant to meglumine antimoniate

1 reference

12 December 2020

A randomized, double-blind, clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the eastern province of Saudi Arabia

1 reference

12 December 2020

Response of cutaneous leishmaniasis (chiclero's ulcer) to treatment with meglumine antimoniate in Southeast Mexico

1 reference

12 December 2020

[Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis]

1 reference

12 December 2020

Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study

1 reference

12 December 2020

Efficacy of cryotherapy and intralesional pentostam in treatment of cutaneous leishmaniasis

1 reference

12 December 2020

Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report

1 reference

12 December 2020

DISSEMINATED CUTANEOUS LEISHMANIASIS; INNOCULATION TO LABORATORY ANIMALS, ELECTRON MICROSCOPY AND FLUORESCENT ANTIBODIES STUDIES

1 reference

12 December 2020

Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony

1 reference

12 December 2020

Liquid nitrogen cryotherapy on Leishmania donovani cutaneous leishmaniasis

1 reference

12 December 2020

Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate

1 reference

12 December 2020

Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.

1 reference

12 December 2020

Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran

1 reference

12 December 2020

[Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B]

1 reference

12 December 2020

Is topical nitric oxide and cryotherapy more effective than cryotherapy in the treatment of old world cutaneous leishmaniasis?

1 reference

12 December 2020

Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis

1 reference

12 December 2020

Ketoconazole in the treatment of cutaneous leishmaniasis in Kuwait

1 reference

12 December 2020

Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate

1 reference

12 December 2020

Activity of azithromycin against Leishmania major in vitro and in vivo

1 reference

12 December 2020

Use of oral miltefosine for cutaneous leishmaniasis in Canadian soldiers returning from Afghanistan

1 reference

12 December 2020

Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate

1 reference

12 December 2020

Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis.

1 reference

12 December 2020

Pentoxifylline suppression of tumor necrosis factor gene transcription

1 reference

12 December 2020

Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial

1 reference

12 December 2020

Management of cutaneous leishmaniasis in adults and children

1 reference

12 December 2020

Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony

1 reference

12 December 2020

Treatment of cutaneous leishmaniasis with cryosurgery

1 reference

12 December 2020

Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.

1 reference

12 December 2020

Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines

1 reference

12 December 2020

A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis

1 reference

12 December 2020

Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala

1 reference

12 December 2020

Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil--an area of Leishmania (V.) braziliensis transmission

1 reference

12 December 2020

Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis.

1 reference

12 December 2020

Cutaneous leishmaniasis. Treatment with combined cryotherapy and intralesional stibogluconate injection

1 reference

12 December 2020

Leishmaniasis due to L. infantum presenting as macrocheilitis and responding to liposomal amphotericin B.

1 reference

12 December 2020

Control of the leishmaniases

1 reference

12 December 2020

Tumor necrosis factor-alpha in human american tegumentary leishmaniasis

1 reference

12 December 2020

Cryosurgery in cutaneous leishmaniasis

1 reference

12 December 2020

10.1007/S40265-013-0132-1

Identifiers

DOI

1 reference

PubMed ID

24170665

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

24170665